Articles On Elixinol Global (ASX:EXL)

  Local markets end +0.13% higher in quasi-comeback Consumer Staples soar on bumper Coles news, but offset by everyone else Small Caps led by Audeara on the back of a massive manufacturing sale   The indignation of Coles has led Consumer...

  Local markets end slightly lower Telco Sector jumps 1.5pc Small Caps led by Way2Vat   The ASX200 has ended a second slumbrous session slightly lower, with a little dribble in the shape of the Star Casino at the corner of its mouth. US M...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

  ASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small cap winners led by American Rare Earths and Appen   The benchmark was shot through the heart by CSL this morning leaving everything else in...

The ASX200 traded steadily throughout the day with the index closing up – but only just –at 0.12 of a per cent. Real estate stocks were the best performers today, while the materials sector shed more than a per cent. In the green A...

Since TGA’s down-scheduling of CBD last year, no products have been sold in Australia But the race to market has been seemingly won by Bod Science following a ‘landmark update’ Stockhead reached out to BOD’s CEO, Jo Patterson   Amidst gro...

ASX 200 benchmark closes 0.5% higher, thanks to Energy surge.  XTX All Technology index has the batteries back in, up 1.26% for the day. Liontown farm-in huge news for E-I-E-I-Olympia Metals.   Local markets opened higher this morning (+0...

The Swiss government has moved quickly to shore up its uniqueness as a centre of commerce – albeit one where the banks eat each other – and hurriedly green-lit (no pun) plans to legalise the sale and consumption of cannabis in Zurich, Switz...

Twitter to allow cannabis companies to advertise in US states where it’s legal Elixnol comes out on top with CannaCare Health arbitration awarded in their favour Avecho expands CBD soft-gel capsule trials with the Lambert Initiative   Twi...

Warrego Energy puts out initial substantial shareholder notice for Gina Rinehart entities following takeover bid Whitehaven Coal finishes November with a new substantial shareholder as two of its directors sell down holdings Neuren Pharma...

Highlights According to Global Wellness Institute, the global wellness industry is a massive US$4.5 trillion market, growing at a historic pace. Last year, Australia’s biggest exports in the supplement industry were essential vitamins,...

On October 6, California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been s...

California, the largest US state passes Assembly Bill 45, formally permitting sale of hemp derived CBD products Bill passage enables clear regulatory frameworks for CBD providers, like Elixinol and retailers; aimed at cleaning up the marke...

The 2021 financial year was overall a very good one for ASX shares. The S&P/ASX 200 Index (ASX: XJO) managed to put on a performance of 24% for the 12 months to 30 June 2021. That makes FY2021 one of the best financial years ever for t...

ShareCafeHidden Gems Webinar Recap – EXL, WOA, OSX & HMD Catch up on the full webinar with presentations from  Elixinol Wellness (ASX: EXL), Wide Open Agriculture (ASX: WOA), Osteopore (ASX: OSX)  & HeraMED (ASX: HMD). Hidden Gems...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Theme of the week Healthcare fi...

Connecticut has become the latest US state to legalise recreational use of marijuana. The state’s governor has just signed a bill to allow people aged 21 and older to possess and consume marijuana, making it the 19th US state to do so. Here...

In the last 24 hours, Australia has gone from two to four states or territories at least partially in lockdown and it impacted on the ASX again. The ASX 200 closed lower again though it was down by just 0.08% after recovering from the intra...

Australian shares appeared to shrug off the latest COVID-19 lockdowns for much of the day, but ultimately closed lower on the day. The ASX200 finished 0.01 per cent down at 7,307, while the ASX Emerging Companies Index fell 1.22 per cent, c...

A cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first time, as medical marijuana gains increased acceptance. The move means that an estimated 116 Aussies with a rare form of epilepsy known as Drav...

Its lead indicators for the current quarter are looking positive as the UK comes out of a hard lockdown and customers have started placing replenishment orders.

The Elixinol Global Ltd (ASX: EXL) share price is rising today after the company released its quarterly activity update. At the time of writing, the Elixinol share price is up 5.88% to 18 cents per share. Elixinol’s focus is the manufactur...

April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open...

ShareCafeHidden Gems Webinar Recap – PFG, EXL, MX1, BRU Catch up on the full webinar with a keynote presentation from Prime Financial Group (ASX: PFG), Elixinol Global (ASX: EXL), Micro-X (ASX: MX1) & Buru Energy (ASX: BRU) Hidden Gems...

ShareCafeElixinol Global (ASX: EXL) – Hidden Gems Webinar Presentation  Presenter – Oliver Horn – Executive Director & Global Chief Executive Officer – Elixinol Global Limited is a global leader in the hemp-derived CBD industry, resear...

The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year...

The S&P/ASX 200 Index (ASX: JXO) is having a pretty decent day today. A the time of writing, the ASX 200 is up a healthy pre-Easter 0.21%. But one group that is doing a quarter-ounce better are ASX cannabis shares. Take Creso Pharma Lt...

Australia’s medical marijuana industry is showing strong growth, according to an industry-leading biannual report. The Freshleaf Analytics report, released this morning, says that patient numbers have grown 15-fold over the past two and a h...

The ASX finished the day slightly in the green, dragged down by tech stocks which lost nearly 1.5 per cent and new float Airtasker (ASX:ART) fell by over 20 per cent. Airtasker debuted at 65 cents and rose over Tuesday and Wednesday to over...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Pot legalisation is creeping across the US state by state, and a major market could be about to join their ranks. Reports out of New York indicate that lawmakers in the Empire State are close to signing a new bill legalising recreational ca...

Elixinol Global Ltd [ASX:EXL] share price is up today after agreeing to acquire Germany's leading CBD brand. The EXL share price is now up 25% YTD, but still down from the 52-week high of 47.5 cents. The post Elixinol Share Price Up 12% af...

Australian cannabis company Elixinol's (ASX: EXL) plans to push further into Europe will be accelerated via the proposed nine million-euro (AUD$13.9 million) acquisition of a leading German CBD brand. The deal will see Elixinol acquire Ca...

Elixinol (ASX:EXL) has become the latest cannabis stock to get into the M&A game, acquiring German company CannaCare. CannaCare is ... Read More The post Elixinol the latest pot stock to M&A; recruits German media entrepreneur to it...

The Elixinol Global Ltd (ASX: EXL) share price has been halted today as the company reported that it would be announcing a potential transaction. Shares in the small-cap cannabis company have not been trading since the start of today. Cons...

Under new group leadership, Elixinol’s business has been substantially repositioned to be more focused with substantial cost reductions and improved cashflows.

Elixinol is now in an enviable position to be able to create a sustainable global consumer goods business with a purpose.

The company recently increased its share purchase plan from the initial A$2 million target to around A$12.3 million to accommodate strong shareholder demand.

Not too many investors are having a good time today. At the time of writing, the S&P/ASX 200 Index (ASX: XJO) is down 2.18% to 6,633points, snapping the healthy momentum that 2021 had brought until now. One ASX sector is fairing a lot...

Lifespot Health (ASX: LSH) has announced a significant investment by major Canadian cannabis investment fund Ela Capital, marking a great achievement for the Australian cannabis industry as well as providing the necessary boost for the acce...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a disappointing decline. The benchmark index is down 0.55% to 6,638.5 points at the time of writing. Four shares that have fallen more than most to...

Elixinol Global Ltd (ASX: EXL) shares are plummeting today, going for just 18.5 cents a share at the time of writing, down 11.09%. The Elixinol share price closed at 21 cents on Friday and opened at 19 cents this morning before dropping to...

The company recently increased its share purchase plan (SPP) from the initial $2 million target to around $12.3 million to accommodate strong shareholder demand after it was significantly oversubscribed.

The corporate regulator has revealed it’s had to make enquiries with 27 ASX listed companies about their 2020 financial reports. The Australian Securities and Investments Commission (ASIC) announced Thursday that it had reviewed financial...

“To exceed our SPP target is a very strong signal that our shareholders have the confidence in our business outlook," says CEO

The company is submitting a Novel Foods application in Europe, expanding its CBD product range across the US given an increasingly favourable regulatory outlook and continuing the growth of its market-leading Hemp Foods Australia brand.

The Elixinol Global Ltd (ASX: EXL) share price tumbled after management issued an update to its share purchase plan (SPP) today. The EXL share price lost 7.6% to 24 cents in after lunch trade when the S&P/ASX 200 Index (Index:^AXJO) ga...

The company has received applications in excess of A$1.3 million of the A$2 million SPP target.

The Elixinol Global Ltd (ASX: EXL) share price soared today, after it was announced that the United Nations (UN) has rescheduled its classification of cannabis. According to the company, this is expected to favourably impact its global bus...